ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes.

Respondek Michalina; Beberok Artur; Rzepka Zuzanna; Rok Jakub; Wrześniok DorotaMedical University of Silesia
Pathology oncology research : POR2020DOI: 10.1007/s12253-019-00715-z
5阅读
引用收藏
分享

摘要

Mcl-1 is a potent antiapoptotic protein and amplifies frequently in many human cancer. Currently, it is considered that the extensively expressed of Mcl-1 protein in melanoma cells is associated with rapid tumor progression, poor prognosis and low chemosensitivity. Therefore, the antiapoptotic protein Mcl-1 could be considered as a potential target for malignant melanoma treatment. The aim of this study was to assess the effect of MIM1 a specific low molecular Mcl-1 protein inhibitor and mixture of MIM1 and dacarbazine on the viability, cell cycle progression and apoptosis induction in amelanotic C32 melanoma cells. The cytotoxic activity of MIM1 towards C32 melanoma cells was examined by the WST-1 test. The Mcl-1 protein level as a drug target in amelanotic melanoma cells was defined by Western blot analysis. Cell cycle progression, DNA fragmentation as well as GSH depletion were determined by fluorescence image cytometer NucleoCounter NC-3000. The obtained results demonstrate that the specific Mcl-1 protein inhibitor - MIM1 decreases cell viability and induce apoptosis (S-phase arrest, DNA fragmentation and redox imbalance) in amelanotic melanoma cells and intensify the proapoptotic properties of DTIC, as a result of interactions with Mcl-1 protein. Taken together, the presented data suggest that Mcl-1 protein is a an important target in malignant melanoma treatment and provide for the first time convincing evidence that MIM1, which inhibits Mcl-1 antiapoptotic protein is able to induce apoptosis and sensitize melanoma cells to alkylating agent.

学科与关键词

关键词
Amelanotic melanomaApoptosisBH3 mimeticsDacarbazineImage cytometryMIM1
相关
加载中…
  • Myeloid cell leukemin-1 inhibitors: a growing arsenal for cancer therapy
    Peng-Ju Zhu; Ze-Zhou Yu; Qi-Dong You; Zheng-Yu JiangDrug Discovery Today, 2020, 25(10): 1873-1882.
  • Discovery of Mcl-1 inhibitors through virtual screening, molecular dynamics simulations and in vitro experiments
    Yue, Jianda; Li, Yaqi; Li, Fengjiao; Zhang, Peng; Li, Yimin; Xu, Jiawei; Zhang, Qianqian; Zhang, Cheng; He, Xiao; Wang, Ying*; Liu, Zhonghua*Computers in Biology and Medicine, 2023, 152: 106350.
  • Homoharringtonine inhibits melanoma cells proliferation in vitro and vivo by inducing DNA damage, apoptosis, and G2/M cell cycle arrest
    Jia-feng Tang*; Guo-li Li; Tao Zhang; Yu-mei Du; Shi-ying Huang; Jian-hua Ran; Jing Li*; Di-long Chen*Archives of Biochemistry and Biophysics, 2021, 108774.
查看全部 →

发表信息

论文状态
公开发表
期刊
Pathology oncology research : POR
发表日期
2020
卷期
第 26 卷, 第 3 期
页码
1465-1474
DOI
10.1007/s12253-019-00715-z
成果收录
CHINAJOURNAL

作者

  • R

    Respondek Michalina (第一作者)

  • B

    Beberok Artur

查看全部 5 位作者收起作者
  • R

    Rzepka Zuzanna

  • R

    Rok Jakub

  • W

    Wrześniok Dorota

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417